Showing 1 - 2 results of 2 for search 'Jorge Camarero', query time: 0.03s Refine Results
  1. 1
    European Medicines Agency extension of indication to include the combination immunotherapy cancer drug treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) for adults with intermediate/poor-risk advanced renal cell carcinoma

    European Medicines Agency extension of indication to include the combination immunotherapy cancer drug treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) for adults with int... by Jorge Camarero, Filip Josephson, Maja Sommerfelt Grønvold, Nikolaos Zafiropoulos, Sahra Ali, Paula van Hennik, Christian Syvertsen, Bjorn Oddvar Strøm, Mats Ökvist, Brigitte Keller-Stanislawski, Elias Pean, Silvy da Rocha Dias, Franscesco Pignatti

    Published 2020-12-01
    Get full text
    Article
  2. 2
    Combinations in the first-line treatment of patients with advanced/metastatic renal cell cancer: regulatory aspects

    Combinations in the first-line treatment of patients with advanced/metastatic renal cell cancer: regulatory aspects by Daniela Melchiorri, Jonas Bergh, Francesco Pignatti, Didier Meulendijks, Paula Hennik, Bjorg Bolstad, Luca Moscetti, Jorge Camarero, Filip Josephson, Maja Sommerfelt Grønvold, Jan Sjoberg, Mihaela Botezatu, Jorn Mulder, Ana Trullas Jimeno, Nikolaos Zafiropoulos, Harald Enzmann

    Published 2020-10-01
    Get full text
    Article

Search Tools: